R87.821
Vaginal low risk human papillomavirus (HPV) DNA test positive
Clinical Classification Guidelines
Medical Intelligence & Overview
A positive result on a vaginal low-risk human papillomavirus (HPV) DNA test (ICD-10 code R87.821) indicates the presence of a specific type of HPV that is generally considered low risk for causing cervical cancer. HPV is a common virus that infects the skin and mucous membranes, and many sexually active individuals will encounter it at some point. This test helps healthcare providers assess whether the HPV types present pose a significant health threat and guides subsequent management or follow-up strategies.
Causes & Symptoms
Clinical Causes: Recent or ongoing sexual activity with an HPV-infected partner Multiple sexual partners over time Inconsistent use of protection such as condoms Weakened immune system, possibly due to immunosuppressive conditions or medications History of previous HPV infections Lowered immune response due to age or health status
Key Symptoms: Often no noticeable symptoms, as many HPV infections are asymptomatic Possible mild vaginal irritation or discharge In some cases, visible genital warts may be present, though low-risk types typically do not cause warts Occasional discomfort or itching in the vaginal area
Diagnostic & Treatment
Diagnosis Path: The detection of low-risk HPV DNA is typically performed during routine screening procedures such as Pap smears or HPV DNA testing. When a test returns positive for low-risk HPV, healthcare providers may recommend additional monitoring or testing depending on overall health, previous results, and other risk factors. While this specific test identifies the presence of HPV DNA, it does not determine if the infection will resolve on its own or persist, which impacts future management decisions.
Treatment Protocols: Most low-risk HPV infections clear spontaneously without the need for medical treatment. If HPV is persistent or if visible genital warts develop, treatment options may include topical medications, cryotherapy, or minor surgical procedures. Regular follow-up appointments may be scheduled to monitor the infection's status, especially if the HPV persists over time. Educating patients about safe sexual practices and HPV vaccination can help reduce the risk of future infections and transmission.
Clinical Advice & FAQs
Billing Guidance
Is R87.821 a billable ICD-10 code?
Yes, R87.821 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report R87.821?
Clinical documentation must specify the nature of Vaginal low risk human papillomavirus (HPV) DNA test positive and any associated comorbidities for accurate reporting.
Cite this Clinical Reference